ScoreWhy is Merit Medical Systems, Inc. ?
1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 11.57
2
Low Debt Company with Strong Long Term Fundamental Strength
3
Flat results in Sep 25
- ROCE(HY) Lowest at 8.3%
- NET PROFIT(Q) Lowest at USD 28.3 MM
4
With ROCE of 9.23%, it has a expensive valuation with a 2.82 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -28.37%, its profits have risen by 4.7% ; the PEG ratio of the company is 11.1
5
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
6
Below par performance in long term as well as near term
- Along with generating -28.37% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Merit Medical Systems, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Merit Medical Systems, Inc. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Merit Medical Systems, Inc.
-30.09%
-0.47
31.46%
S&P 500
18.81%
1.04
19.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.91%
EBIT Growth (5y)
32.91%
EBIT to Interest (avg)
11.57
Debt to EBITDA (avg)
1.15
Net Debt to Equity (avg)
0.24
Sales to Capital Employed (avg)
0.66
Tax Ratio
20.40%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
7.65%
ROE (avg)
7.50%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
2.69
EV to EBIT
24.71
EV to EBITDA
14.27
EV to Capital Employed
2.37
EV to Sales
3.02
PEG Ratio
8.44
Dividend Yield
NA
ROCE (Latest)
9.61%
ROE (Latest)
8.30%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 267.6 MM
RAW MATERIAL COST(Y)
Fallen by -5.25% (YoY
NET SALES(Q)
Highest at USD 384.26 MM
-3What is not working for the Company
ROCE(HY)
Lowest at 8.3%
NET PROFIT(Q)
Lowest at USD 28.3 MM
Here's what is working for Merit Medical Systems, Inc.
Operating Cash Flow
Highest at USD 267.6 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 384.26 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Raw Material Cost
Fallen by -5.25% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 34.24 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Merit Medical Systems, Inc.
Net Profit
Lowest at USD 28.3 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
